NeoGenomics (NEO) Tops Q2 EPS by 1c, Beats on Revenues; Reiterates Guidance

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $66.1 million versus the consensus estimate of $62.97 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance